The market for GLP-1 drugs is projected to exceed $200 billion in annual sales by 2031, according to Morningstar Equity Research. Current market leaders include Novo Nordisk NVO and Eli Lilly LLY with ...

Here are some investing mistakes I've made over the years and how you can avoid them on your own wealth-building journey.

Sir Chris Whitty tells the Covid-19 Inquiry the NHS has 'slipped backwards' since the pandemic at sharing vital patient data, ...

A HUGE study that has been launched to find treatments for diseases by measuring how the proteins circulating in our bodies ...

Pfizer Inc (PFE) stock saw a decline, ending the day at $26.3 which represents a decrease of $-0.19 or -0.72% from the prior close of $26.49. The stock opened at $26.4 and touched a low of $26.22 ...

MHRA’s independence also questioned during Commons debate, with regulator accused of being too close to companies it ...

We recently published a list of 12 Undervalued Defensive Stocks for 2025. In this article, we are going to take a look at ...

Pfizer CEO Albert Bourla joins CNBC's 'Special Report' as President-elect Donald Trump is inaugurated as the 47th U.S.

Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

While pediatric atopic dermatitis cases rose globally between 2000 and 2021, the prevalence rate dropped, showing important ...

Bierman, chief market technician at Theo Trade and an adjunct professor of finance at Loyola University Chicago, says investors will be dealing with greater stock-market volatility and uncertainty ...

Will Trump’s tax cuts and deregulation spark gains in S&P 500 sectors like financials and energy? Discover key sector trends and stock opportunities.